Published in Appl Immunohistochem Mol Morphol on December 01, 2002
Verrucous hyperplasia: A clinico-pathological study. J Oral Maxillofac Pathol (2011) 0.98
Comparative study of the expression of p53, Ki67, E-cadherin and MMP-1 in verrucous hyperplasia and verrucous carcinoma of the oral cavity. Head Neck Pathol (2007) 0.93
Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma. J Surg Res (2008) 0.85
Expression of transforming growth factor-alpha and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance. World J Gastroenterol (2004) 0.79
Verrucous Hyperplasia: Case report and differential diagnosis. Sultan Qaboos Univ Med J (2017) 0.75
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res (2006) 8.08
Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res (2009) 2.10
Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer (2004) 1.73
One-step nucleic acid amplification assay also predicts axillary lymph node status in breast cancer patients: further molecular diagnostic evidence. Eur J Cancer (2013) 1.06
The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer. PLoS One (2012) 1.06
Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. Am J Clin Pathol (2002) 1.05
Automatic breast cancer grading of histopathological images. Conf Proc IEEE Eng Med Biol Soc (2008) 1.04
Spindle cell lesions of the breast--the pathologic differential diagnosis. Breast Cancer Res Treat (2007) 1.03
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance. Haematologica (2011) 0.99
Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells. Mol Cancer Res (2009) 0.98
p63 is useful in the diagnosis of mammary metaplastic carcinomas. Pathology (2006) 0.98
PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer. Cancer Biol Ther (2010) 0.92
Increased c-kit (CD117) expression in malignant mammary phyllodes tumors. Mod Pathol (2004) 0.89
Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases. Hum Pathol (2004) 0.89
Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells. Exp Cell Res (2010) 0.87
Increased p53 protein expression in malignant mammary phyllodes tumors. Mod Pathol (2002) 0.86
Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors. Mod Pathol (2003) 0.86
Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. J Proteome Res (2008) 0.86
Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors. Breast Cancer Res Treat (2008) 0.85
Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers. Pathology (2010) 0.83
ERp29 induces breast cancer cell growth arrest and survival through modulation of activation of p38 and upregulation of ER stress protein p58IPK. Lab Invest (2011) 0.82
Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours. Pathology (2009) 0.81
Consolidation of the North Shore-LIJ Health System anatomic pathology services: the challenge of subspecialization, operations, quality management, staffing, and education. Am J Clin Pathol (2013) 0.81
Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. J Low Genit Tract Dis (2005) 0.80
Proteomic characterization of differentially expressed proteins in breast cancer: Expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER-2/neu status. Proteomics Clin Appl (2008) 0.80
Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma. Appl Immunohistochem Mol Morphol (2014) 0.79
Fine-needle aspiration cytology of metaplastic carcinoma of the breast. J Clin Pathol (2006) 0.79
Malignant mesenchymoma arising from a uterine leiomyoma in the menopause. Gynecol Oncol (2004) 0.79
Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours. J Clin Pathol (2006) 0.78
Molecular-assisted immunohistochemical optimization. Acta Histochem (2009) 0.78
A cognitive virtual microscopic framework for knowledge-based exploration of large microscopic images in breast cancer histopathology. Conf Proc IEEE Eng Med Biol Soc (2009) 0.78
Postirradiation sarcoma of the sphenoid bone--a case report. Ann Acad Med Singapore (2006) 0.78
Involvement of the appendix and palate by pleomorphic variant mantle cell lymphoma. Leuk Lymphoma (2006) 0.78
Utility of cytokeratin 5/6 and high-molecular-weight keratin in evaluation of cauterized surgical margins in excised specimens of breast ductal carcinoma in situ. Ann Diagn Pathol (2011) 0.77
Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours. Histopathology (2012) 0.76
Recent insights into the molecular pathogenesis of mammary phyllodes tumours. J Clin Pathol (2013) 0.76
E-cadherin expression in the epithelial components of mammary phyllodes tumors. Hum Pathol (2012) 0.75
Uterine malignant mixed müllerian tumour with pilomatrixoma-like areas. Pathology (2003) 0.75
Renal cell carcinoma bony metastasis treatment. Ann Acad Med Singapore (2008) 0.75
Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens. Cancer Cytopathol (2014) 0.75
Ossifying fibromyxoid tumor of the breast mimicking fibroadenoma: a case report and differential diagnoses. Arch Pathol Lab Med (2014) 0.75